Catalent Inc Business Finance Contracts & Agreements

52 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment to Registration Rights Agreement, dated as of April 17, 2024, by and among Catalent, Inc., Green Equity Investors VII, L.P., Green Equity Investors Side VII, L.P., LGP...
Registration Rights Agreements
Catalent Inc
Pharmaceuticals
2024
Long Term International Assignment Letter, dated October 10, 2022, by and between Catalent Pharma Solutions LLC and Manja Boerman
Assignment Agreements
Catalent Inc
Pharmaceuticals
2023
Form of Restricted Stock Unit Agreement for Non-Employee Directors
Stock Agreements
Catalent Inc
Pharmaceuticals
NJ
2023
Amendment No. 10 to Amended and Restated Credit Agreement, dated as of November 22, 2023, by and among Catalent Pharma Solutions, Inc., PTS Intermediate Holdings LLC, JPMorgan...
Credit Agreements
Catalent Inc
Pharmaceuticals
NY
2023
Amendment No. 9 to Amended and Restated Credit Agreement, dated as of September 27, 2023, by and among Catalent Pharma Solutions, Inc., PTS Intermediate Holdings LLC, JPMorgan...
Credit Agreements
Catalent Inc
Pharmaceuticals
NY
2023
Form of Restricted Stock Unit Agreement for non-U.S. Non-Employee Directors (fiscal 2023)
Stock Agreements
Catalent Inc
Pharmaceuticals
NJ
2022
Form of Restricted Stock Unit Agreement for U.S. Non-Employee Directors (fiscal 2023)
Stock Agreements
Catalent Inc
Pharmaceuticals
NJ
2022
Description of the Companys Common Stock, par value $0.01 per share
Stock Agreements
Catalent Inc
Pharmaceuticals
DE
2022
Indenture, dated September 29, 2021, by and among Catalent Pharma Solutions, Inc., the subsidiary guarantors named therein, and Deutsche Bank Trust Company Americas, as trustee
Indenture Agreements
Catalent Inc
Pharmaceuticals
NY
2021
Membership Interest Purchase Agreement, dated August 29, 2021, by and among Catalent Pharma Solutions, Inc., Bettera Holdings, LLC, the members of Bettera Holdings, LLC, and...
Purchase Agreements
Catalent Inc
Pharmaceuticals
DE
2021
Indenture, dated February 22, 2021, by and among Catalent Pharma Solutions, Inc., the subsidiary guarantors named therein, and Deutsche Bank Trust Company Americas, as trustee
Indenture Agreements
Catalent Inc
Pharmaceuticals
NY
2021
Form of Restricted Stock Unit Agreement for U.S. Non-Employee Directors
Stock Agreements
Catalent Inc
Pharmaceuticals
NJ
2020
Underwriting Agreement, dated June 10, 2020, between the Company and RBC Capital Markets, LLC
Underwriting Agreements
Catalent Inc
Pharmaceuticals
2020
Indenture, dated March 2, 2020, by and among Catalent Pharma Solutions, Inc., the subsidiary guarantors named therein, Deutsche Trustee Company Limited, as trustee, Deutsche Bank...
Indenture Agreements
Catalent Inc
Pharmaceuticals
DE
2020
Underwriting Agreement, dated February 3, 2020, among the Company, J.P. Morgan Securities LLC and UBS Securities LLC
Underwriting Agreements
Catalent Inc
Pharmaceuticals
2020
Stock Purchase Agreement, dated as of February 2, 2020, among Catalent Pharma Solutions, Inc., Orgenesis Inc. and GPP-II Masthercell, LLC
Stock Agreements
Catalent Inc
Pharmaceuticals
DE
2020
Description of the Companys Common Stock, par value $0.01
Stock Agreements
Catalent Inc
Pharmaceuticals
DE
2019
Indenture, dated June 27, 2019, by and among Catalent Pharma Solutions, Inc., the subsidiary guarantors named therein, and Deutsche Bank Trust Company Americas, as trustee
Indenture Agreements
Catalent Inc
Pharmaceuticals
NY
2019
Registration Rights Agreement, dated as of May 17, 2019, by and among Catalent, Inc., Green Equity Investors VII, L.P., Green Equity Investors Side VII, L.P., LGP Associates VII-A...
Registration Rights Agreements
Catalent Inc
Pharmaceuticals
NY
2019
Form of 2018 OIP Performance Share Unit Agreement for Non-U.S. Employees (three-year performance period)
Share Agreements
Catalent Inc
Pharmaceuticals
NJ
2019
Form of 2018 OIP Performance Share Unit Agreement for U.S. Employees (three-year performance period)
Share Agreements
Catalent Inc
Pharmaceuticals
NJ
2019
Form of 2018 OIP Restricted Stock Unit Agreement for Non-U.S. Employees
Stock Agreements
Catalent Inc
Pharmaceuticals
NJ
2019
Form of 2018 OIP Restricted Stock Unit Agreement for U.S. Employees
Stock Agreements
Catalent Inc
Pharmaceuticals
NJ
2019
Equity Commitment and Investment Agreement, dated as of April 14, 2019, by and among Catalent, Inc. Green Equity Investors VII, L.P. and Green Equity Investors Side VII, L.P....
Exchange Agreements
Catalent Inc
Pharmaceuticals
NY
2019
Catalent, Inc. 2019 Employee Stock Purchase Plan
Stock Agreements
Catalent Inc
Pharmaceuticals
DE
2018
Form of Performance Restricted Stock Agreement for Non-U.S. Employees (for the performance period July 1, 2018 through June 30, 2021)
Stock Agreements
Catalent Inc
Pharmaceuticals
NJ
2018
Form of Performance Restricted Stock Agreement for U.S. Employees (for the performance period July 1, 2018 through June 30, 2021)
Stock Agreements
Catalent Inc
Pharmaceuticals
NJ
2018
Form of the Performance Share Unit Agreement for Non-U.S. Employees (for the performance period July 1, 2018 through June 30, 2021)
Share Agreements
Catalent Inc
Pharmaceuticals
NJ
2018
Form of the Performance Share Unit Agreement for U.S. Employees (for the performance period July 1, 2018 through June 30, 2021)
Share Agreements
Catalent Inc
Pharmaceuticals
NJ
2018
Form of Performance Restricted Stock Agreement for Non-U.S. Employees (for the performance period July 1, 2017 through June 30, 2020)
Stock Agreements
Catalent Inc
Pharmaceuticals
NJ
2018
Form of Performance Restricted Stock Agreement for U.S. Employees (for the performance period July 1, 2017 through June 30, 2020)
Stock Agreements
Catalent Inc
Pharmaceuticals
NJ
2018
Form of Performance Restricted Stock Agreement for Non-U.S. Employees (for the performance period July 1, 2016 through June 30, 2019)
Stock Agreements
Catalent Inc
Pharmaceuticals
NJ
2018
Form of Performance Restricted Stock Agreement for U.S. Employees (for the performance period July 1, 2016 through June 30, 2019)
Stock Agreements
Catalent Inc
Pharmaceuticals
NJ
2018
Underwriting Agreement, dated July 24, 2018, between the Company, J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC and RBC Capital Markets, LLC, as representatives of the...
Underwriting Agreements
Catalent Inc
Pharmaceuticals
2018
Form of the Performance Share Unit Agreement for Non-U.S. Employees for the performance period July 1, 2017 through June 30, 2020
Share Agreements
Catalent Inc
Pharmaceuticals
NJ
2017
Form of the Performance Share Unit Agreement for U.S. Employees for the performance period July 1, 2017 through June 30, 2020
Share Agreements
Catalent Inc
Pharmaceuticals
NJ
2017
Amendment No. 3 to Amended and Restated Credit Agreement, dated as of October 18, 2017, by and among Catalent Pharma Solutions, Inc., PTS Intermediate Holdings LLC, Morgan Stanley...
Credit Agreements
Catalent Inc
Pharmaceuticals
KS
2017
Indenture, dated October 18, 2017, by and among Catalent Pharma Solutions, Inc., the subsidiary guarantors named therein and Deutsche Bank Trust Company Americas, as trustee
Indenture Agreements
Catalent Inc
Pharmaceuticals
NY
2017
Underwriting Agreement, dated September 26, 2017, between the Company, Morgan Stanley & Co. LLC, J.P. Morgan Securities LLC and RBC Capital Markets, LLC, as representatives of the...
Underwriting Agreements
Catalent Inc
Pharmaceuticals
2017
Interest Purchase Agreement, dated September 18, 2017, by and among Catalent Pharma Solutions, Inc., Cook Pharmica LLC, Cook Group Incorporated, and, solely for purposes of...
Exchange Agreements
Catalent Inc
Pharmaceuticals
DE
2017